logo

For the Inventor, By the Inventor

San Jose, CA, United States of America

Reviva Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 27

% Expired Patents = 7.4


Trademarks = 1

Forward Citations = 45

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Laxminarayan Bhat (27 out of 39 patents)

silverMedal Kouacou Adiey (14 out of 15 patents)

bronzeMedal Prabhu Prasad Mohapatra (13 out of 13 patents)

4.  Seema Rani Bhat (11 out of 17 patents)

5.  Ellen M Wallis (1 out of 1 patent)

6.  Marc Cantillon (1 out of 1 patent)

7.  Sureshbabu Dadiboyena (1 out of 1 patent)


Core Competencies:
Pulmonary Fibrosis
Pulmonary Hypertension
Arylpiperazine Derivatives
Attention Deficit Hyperactivity Disorder
Cycloalkylmethylamines
Phenylcycloalkylmethylamine
Cholinesterase Inhibitors
Quinazolinedione Derivatives
Atypical Antipsychotic Agents
Piperazine Based Antipsychotic Agents

27 patents:

1. 12053477 - Methods for treating pulmonary fibrosis (2024-08-06),
2. 10441590 - Methods for treating pulmonary hypertension (2019-10-15),
3. 9975862 - Arylpiperazine derivatives and methods of utilizing same (2018-05-22),
4. 9907803 - Methods for treating attention deficit hyperactivity disorder (2018-03-06),
5. 9695116 - Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives (2017-07-04),
6. 9604944 - Arylpiperazine derivatives and methods of utilizing same (2017-03-28),
7. 9302981 - Synthesis, methods of using, and compositions of cycloalkylmethylamines (2016-04-05),
8. 9296681 - Cycloalkylmethylamines (2016-03-29),
9. 9255076 - Arylpiperazine derivatives and methods of utilizing same (2016-02-09),
10. 9238625 - Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives (2016-01-19),
11. 9096515 - Methods of using cycloalkylmethylamine derivatives (2015-08-04),
12. 8980883 - Arylpiperazine derivatives and methods of utilizing same (2015-03-17),
13. 8859552 - Methods of utilizing arylpiperazine derivatives (2014-10-14),
14. 8669285 - Synthesis, methods of using, and compositions of cycloalkylmethylamines (2014-03-11),
15. 8604244 - Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives (2013-12-10),
Company Overview
Reviva Pharmaceuticals, Inc. is a biopharmaceutical company based in San Jose, California, focused on developing innovative therapies for central nervous system disorders and other unmet medical needs. The company specializes in the research and development of novel drug candidates that leverage its proprietary technology platforms. Reviva aims to address significant health challenges through its commitment to advancing scientific knowledge and improving patient outcomes in the pharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Reviva Pharmaceuticals, Inc. USPTO Patent Assignee Logo
27 Patents

#280 in San Jose, CA

#2,935 in California

#12,432 in US

#24,046 in the World

San Jose, CA (US)
San Jose, CA, United States of America

Reviva Pharmaceuticals, Inc.

Forward Citations = 45

7 inventors:

goldMedal Laxminarayan Bhat (27 out of 39 patents)

silverMedal Kouacou Adiey (14 out of 15 patents)

bronzeMedal Prabhu Prasad Mohapatra (13 out of 13 patents)

4.  Seema Rani Bhat (11 out of 17 patents)

5.  Ellen M Wallis (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Reviva Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/reviva-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…